The MIRA Surgical System Proceeds to FDA Substantive Review for Market Authorization Under the De Novo Classification Pathway

Virtual Incision Has Achieved a Significant Milestone in Its De Novo Request and is Closer to Potential Commercial Readiness  Lincoln, Neb. – May 18, 2023 – Virtual Incision Corporation today announced its De Novo request was submitted and is under substantive review by the U.S. Food and Drug Administration (FDA). [...]

2023-05-19T18:55:06+01:00May 18th, 2023|All News, Company News|

Relievant Medsystems Announces More Than 10,000 Patients Treated with the Intracept® Procedure for Vertebrogenic Low Back Pain

MINNEAPOLIS, May 09, 2023 (GLOBE NEWSWIRE) -- Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic low back pain, today announced that more than 10,000 patients have been treated with the Intracept® Procedure. This is the latest in a series of milestone accomplishments as the [...]

2023-05-10T08:04:11+01:00May 9th, 2023|All News, Company News|

Relievant Medsystems Raises $50 Million to Advance the Treatment for Chronic Vertebrogenic Low Back Pain

MINNEAPOLIS, April 19, 2023 (GLOBE NEWSWIRE) --  Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic pain, a type of chronic low back pain (CLBP), today announced that it has completed the close of its $50 million Series G financing. The financing was led by [...]

2023-04-20T15:51:11+01:00April 19th, 2023|All News, Company News|

Gynesonics Names Industry Veteran Skip Baldino President and CEO, Announces $25M Financing to Expand Worldwide Commercialization

REDWOOD CITY, Calif., April 11, 2023 (GLOBE NEWSWIRE) -- Gynesonics®, Inc. a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced that Skip Baldino was appointed in early March to the role of President and Chief Executive Officer of the company. Mr. [...]

2023-04-13T10:58:51+01:00April 13th, 2023|All News, Company News|

Medartis announces completion of a CHF 30 million capital increase to finance its additional stake in Keri Medical

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Basel, 17 March 2023: Medartis Holding AG (SIX: MED), an orthopaedic company specialising in head and extremity surgery, today announced the successful completion of a small capital increase of CHF 30 million in a private placement to finance an additional stake [...]

2023-05-02T10:31:51+01:00March 17th, 2023|All News, Company News|

Neurovascular technology Q&A with Endeavour Vision’s Investment Manager, Toby AuWerter

As an investor in healthcare technologies, we are always on the lookout for areas of unmet need where new technologies have the potential to improve patient outcomes. The neurovascular technology sector is one such field. Neurovascular conditions occur when an area of the brain is affected by restricted blood flow [...]

2023-03-28T14:18:15+01:00March 7th, 2023|All News, Blog, Medtech|

The Innovation Continues for Robotic-Assisted Surgery – Virtual Incision Completes FDA Investigational Device Exemption (IDE) Clinical Study for MIRA

Study results will be used to support the first FDA De Novo request for market authorization of the MIRA Surgical System as Virtual Incision makes progress towards its mission to expand RAS access Lincoln, Neb. – February 22, 2023 – Virtual Incision Corporation, a medical device company spearheading the [...]

2023-03-28T14:20:01+01:00February 22nd, 2023|All News, Company News|

Miach Orthopaedics Secures $40 Million Financing – Funds to Expand U.S. Commercialization of BEAR® Implant for Treatment of ACL Tears

WESTBOROUGH, Massachusetts – January 24, 2023 – Miach Orthopaedics, Inc., a company transforming the treatment of anterior cruciate ligament (ACL) tears from reconstruction to restoration with the Bridge-Enhanced ACL Restoration (BEAR®) Implant, today announced closing of a $40 million financing round. The funds will enable ongoing operations and expand [...]

2023-03-28T14:20:57+01:00January 25th, 2023|All News, Blog, Company News, Investment, Medtech|

Relievant Medsystems Announces Highest Quality of Evidence Ranking for Basivertebral Nerve Ablation in ASPN Back Guideline for Interventional Low Back Pain Treatments

MINNEAPOLIS, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic pain, a type of chronic low back pain (CLBP), today announced that basivertebral nerve (BVN) ablation received a Grade A Quality of Evidence Ranking with High Level of Certainty [...]

2023-03-30T14:43:26+01:00January 9th, 2023|All News, Blog|

Interview with Tyler Binney, CEO of Relievant

Tyler Binney joined Relievant as President and CEO in 2021. We interviewed him to learn about Relievant’s breakthrough Intracept® Procedure, which could bring relief to tens of millions of US adults living with disabling vertebrogenic lower back pain. Tell us about chronic lower back pain. How does it impact [...]

2023-03-30T15:21:22+01:00December 13th, 2022|All News, Blog|
Go to Top